LAG3 and neoplasm: Furthermore, the mLAG-3-specific Nb 3132 was able to quantify dynamic LAG-3 expression within the TME and tumor-draining lymph nodes of PD-1-treated MC38 tumor-bearing mice, revealing a compensatory LAG-3 upregulation as a consequence of PD-1 blockade [71].